4l7d
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | ==Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-5-methyl-1-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}cyclohexanecarboxylic acid== | |
- | + | <StructureSection load='4l7d' size='340' side='right' caption='[[4l7d]], [[Resolution|resolution]] 2.25Å' scene=''> | |
- | { | + | == Structural highlights == |
+ | <table><tr><td colspan='2'>[[4l7d]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4L7D OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4L7D FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=1VX:(1S,2R)-2-{[(1S)-5-METHYL-1-[(1-OXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)METHYL]-3,4-DIHYDROISOQUINOLIN-2(1H)-YL]CARBONYL}CYCLOHEXANECARBOXYLIC+ACID'>1VX</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene></td></tr> | ||
+ | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4l7b|4l7b]], [[4l7c|4l7c]], [[4n1b|4n1b]]</td></tr> | ||
+ | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">KEAP1, INRF2, KIAA0132, KLHL19 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4l7d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4l7d OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4l7d RCSB], [http://www.ebi.ac.uk/pdbsum/4l7d PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | An X-ray crystal structure of Kelch-like ECH-associated protein (Keap1) co-crystallised with (1S,2R)-2-[(1S)-1-[(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)methyl]-1,2,3,4-tetrah ydroisoquinolin-2-carbonyl]cyclohexane-1-carboxylic acid (compound (S,R,S)-1 a) was obtained. This X-ray crystal structure provides breakthrough experimental evidence for the true binding mode of the hit compound (S,R,S)-1 a, as the ligand orientation was found to differ from that of the initial docking model, which was available at the start of the project. Crystallographic elucidation of this binding mode helped to focus and drive the drug design process more effectively and efficiently. | ||
- | + | Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex.,Jnoff E, Albrecht C, Barker JJ, Barker O, Beaumont E, Bromidge S, Brookfield F, Brooks M, Bubert C, Ceska T, Corden V, Dawson G, Duclos S, Fryatt T, Genicot C, Jigorel E, Kwong J, Maghames R, Mushi I, Pike R, Sands ZA, Smith MA, Stimson CC, Courade JP ChemMedChem. 2014 Feb 6. doi: 10.1002/cmdc.201300525. PMID:24504667<ref>PMID:24504667</ref> | |
- | + | ||
- | == | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
- | + | </div> | |
+ | |||
+ | ==See Also== | ||
+ | *[[Kelch-like ECH-associated protein 1|Kelch-like ECH-associated protein 1]] | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
- | [[Category: Albrecht, C | + | [[Category: Albrecht, C]] |
- | [[Category: Barker, J J | + | [[Category: Barker, J J]] |
- | [[Category: Barker, O | + | [[Category: Barker, O]] |
- | [[Category: Beaumont, E | + | [[Category: Beaumont, E]] |
- | [[Category: Bromidge, S | + | [[Category: Bromidge, S]] |
- | [[Category: Brookfield, F | + | [[Category: Brookfield, F]] |
- | [[Category: Brooks, M | + | [[Category: Brooks, M]] |
- | [[Category: Ceska, T | + | [[Category: Ceska, T]] |
- | [[Category: Courade, J P | + | [[Category: Courade, J P]] |
- | [[Category: Crabbe, T | + | [[Category: Crabbe, T]] |
- | [[Category: Duclos, S | + | [[Category: Duclos, S]] |
- | [[Category: Fryatt, T | + | [[Category: Fryatt, T]] |
- | [[Category: Jigorel, E | + | [[Category: Jigorel, E]] |
- | [[Category: Jnoff, E | + | [[Category: Jnoff, E]] |
- | [[Category: Kwong, J | + | [[Category: Kwong, J]] |
- | [[Category: Sands, Z | + | [[Category: Sands, Z]] |
- | [[Category: Smith, M A | + | [[Category: Smith, M A]] |
[[Category: Beta-propeller]] | [[Category: Beta-propeller]] | ||
[[Category: Kelch domain]] | [[Category: Kelch domain]] |
Revision as of 09:03, 15 February 2015
Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-5-methyl-1-[(1-oxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}cyclohexanecarboxylic acid
|
Categories: Human | Albrecht, C | Barker, J J | Barker, O | Beaumont, E | Bromidge, S | Brookfield, F | Brooks, M | Ceska, T | Courade, J P | Crabbe, T | Duclos, S | Fryatt, T | Jigorel, E | Jnoff, E | Kwong, J | Sands, Z | Smith, M A | Beta-propeller | Kelch domain | Kelch repeat motif | Nrf2 | Protein-small molecule complex | Stress sensor | Transcription-inhibitor complex